Piper Jaffray

Piper Jaffray is a prominent full-service investment bank and asset management firm with a global presence, headquartered in Minneapolis. Established in 1895, the company offers a range of financial services including mergers and acquisitions, public offerings, public finance, financial restructuring, institutional brokerage, and securities research. Its principal subsidiary, Piper Jaffray & Co., serves a diverse clientele comprising corporations, institutional investors, and public entities. Additionally, the firm has a private equity arm, Piper Jaffray Merchant Banking, which focuses on investing in private, commercially viable businesses with significant growth potential. With offices throughout the United States and in key international cities such as London, Hong Kong, and Zurich, Piper Jaffray continues to leverage its extensive industry expertise and resources to meet the needs of its clients.

Deborah Schoneman

Managing Director and President

Thomas Smith

Chief Strategy Officer

Brad Winges

Managing Director and President of PJIM

59 past transactions

Moxe Health

Series B in 2022
Moxe Health streamlines the bi-directional exchange of clinical data between health plans and provider systems. The company provide solutions for risk adjustment, HEDIS and Star ratings, claims denial management, HCC reconciliation, patient summary, ADT notifications, and care gap management. Plans seamlessly send back data and insights while never straying from clinicians’ EHR workflows. Moxe’s clinical data clearinghouse allows health plans to easily receive information from health systems. Health plans can then seamlessly send back data and insights. With automated solutions for risk adjustment, quality, and care management programs, Moxe facilitates access to the information essential to your success in the market shift to value-based care. Moxe’s neutrality in providing data connectivity lets you realize the full potential of your existing investments in population health, quality, and analytics solutions.

Paragon 28

Series B in 2020
Paragon 28, Inc. specializes in developing and providing surgical solutions for foot and ankle procedures, offering a range of products that include forefoot, midfoot, and hindfoot plates, screws, allograft bone systems, and interference screws and staples. Their offerings include innovative solutions such as the PHANTOM Lapidus Intramedullary Nail for arthrodesis correction, the Proximal Rotational Metatarsal Osteotomy system for bunion correction, and the Paratrooper Plantar Plate Repair System which simplifies plantar plate repair procedures. Additionally, the JAWS Nitinol Staple System is designed for osteotomy and arthrodesis procedures. Founded in 2010 and headquartered in Englewood, Colorado, Paragon 28 also maintains a location in Dublin, Ireland, reinforcing its commitment to addressing the needs of foot and ankle surgeons.

Akoya Biosciences

Series D in 2019
Akoya Biosciences is a spatial biology company offering the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials.

Clinicient

Venture Round in 2019
Clinicient, Inc. is a technology company specializing in software solutions for outpatient rehabilitation clinics, primarily focusing on physical therapy. Founded in 1998 and based in Portland, Oregon, Clinicient offers a range of products including TotalInsight, which integrates cloud-based electronic medical records (EMR) with billing services and revenue cycle management. Additionally, PracticeInsight provides a unified system for EMR and billing, while InsightEMR is a customizable EMR tailored for therapy providers. The company also addresses Medicare requirements with services such as functional limitation reporting and claims management. Clinicient’s platform streamlines patient registration, scheduling, clinical documentation, and billing processes, enabling clinics to enhance revenue management and improve payment outcomes.

Sandler O’Neill & Partners

Acquisition in 2019
Sandler O’Neill + Partners is a full-service investment banking firm and broker-dealer focused on the financial services sector. Its clients include a wide variety of financial firms nationwide, and increasingly, around the globe. The firm provides the full suite of investment banking services, including merger and acquisition advisory, capital markets, fixed income and equity trading and sales, equity research, balance sheet management, mortgage finance and consulting services to financial institutions and their investors. Sandler O’Neill is a partnership, and different by design. Since the firm’s founding in 1988, its partners have sought to provide banks, thrifts and other financial services companies with an alternative to large Wall Street banking firms. The firm's focus has always been to enhance franchise value for clients within known, managed risk parameters. We provide clients a wealth of experience and knowledge more critical to them today than ever.

Elligo Health Research

Series C in 2019
Elligo Health Research is revolutionizing the clinical research industry with a novel approach to common trial challenges including patient participation and enrollment, and physician participation. They provide physicians and their patients the opportunity to participate in clinical trials using advanced health care informatics. Improved access to physicians and patients means sponsors reach trial enrollment goals faster, and new products are accelerated to market, benefiting patients everywhere.

Weeden & Co

Acquisition in 2019
Weeden & Co. is an employee-owned limited partnership. This structure allows all employees to participate in the success of the firm. Their success is wholly dependent upon listening to our clients, and upon delivering superior execution solutions. Their partnership fosters teamwork, loyalty, and a deep appreciation for each other and for our clients.

Foodsby

Series B in 2018
Foodsby is an online marketplace connecting employees in office buildings with local restaurants to provide hard-working professionals with a variety of easy lunch options. Individuals place orders online, orders are aggregated via Foodsby.com, and the restaurants make one simple delivery with all orders. We're giving hardworking professionals the freedom to eat well and remain productive in their work-life. Foodsby brings more meal options and variety to customers by connecting with local and national restaurant brands they know and love. It was founded in 2012 and is based in Minneapolis, Minnesota, USA.

Xenex

Venture Round in 2017
Xenex is a company focused on reducing healthcare-associated infections (HAIs) through its advanced ultraviolet disinfection technology. Founded in 2009 and based in San Antonio, Texas, Xenex has developed a portable device that utilizes pulsed xenon UV light to eliminate harmful microorganisms in hospital environments. Since launching its disinfection system in June 2010, the company’s devices have been integrated into infection control protocols in nearly three hundred hospitals across the United States. By effectively reducing the bacterial load that contributes to HAIs, Xenex aims to enhance patient safety and safeguard healthcare staff, ultimately striving to save lives and alleviate suffering in healthcare settings.

OrthoAccel Technologies

Series C in 2017
OrthoAccel Technologies, Inc. is a medical device company based in Bellaire, Texas, that specializes in developing, manufacturing, and selling innovative products for dental care and orthodontic treatment. The company offers the AcceleDent Optima, which connects patients and orthodontic practices while monitoring tooth movement, and the AcceleDent Aura, which employs SoftPulse technology to deliver gentle micro pulses that enhance bone remodeling. These devices include an activator, mouthpiece, USB extension cable with power adapter, and a travel case. OrthoAccel sells its products through orthodontic practices in the United States and internationally. Established in 2006, the company continues to focus on advancing orthodontic care through proprietary technologies, including partnerships with leading researchers in the field.

Torax Medical

Series E in 2016
Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.

Norsk Titanium

Venture Round in 2016
Norsk Titanium AS designs and manufactures 3D-printed, structural titanium production machinery for the aerospace industry. Its products include MERKE IV and Gen-4 Machine. The company’s products are based on its patented technology, Rapid Plasma Deposition (RPD). It offers its products to aerospace, defense, and commercial customers, including the oil and gas industry. Norsk Titanium AS was formerly known as Norsk Titanium Components AS. The company was founded in 2004 and is based in Hønefoss, Norway. It has a product development and qualification center in Plattsburgh, New York. Norsk Titanium AS operates as a subsidiary of Scatec AS.

OrthoAccel Technologies

Series C in 2016
OrthoAccel Technologies, Inc. is a medical device company based in Bellaire, Texas, that specializes in developing, manufacturing, and selling innovative products for dental care and orthodontic treatment. The company offers the AcceleDent Optima, which connects patients and orthodontic practices while monitoring tooth movement, and the AcceleDent Aura, which employs SoftPulse technology to deliver gentle micro pulses that enhance bone remodeling. These devices include an activator, mouthpiece, USB extension cable with power adapter, and a travel case. OrthoAccel sells its products through orthodontic practices in the United States and internationally. Established in 2006, the company continues to focus on advancing orthodontic care through proprietary technologies, including partnerships with leading researchers in the field.
Simmons & Company International is one of the largest and most experienced independent investment banks specializing in the energy industry, offering unparalleled M&A advisory, capital markets execution and investment research. By leveraging the collective knowledge of their growing team of approximately 150 professionals, they stay on the forefront of the industry's trends, drivers and developments and are also positioned to access the most strategic opportunities for their clients. Over the last four decades they have established theirselves as a premier partner in virtually every energy sector, serving a worldwide client base ranging from institutional investors, public and private companies and private equity firms. Their extensive market coverage and industry knowledge has not only profoundly shaped their unique perspective, but empowers clients to understand the energy sector in a new light.

GutCheck

Series D in 2015
GutCheck is a marketing research company based in Denver, Colorado, founded in 2009. It specializes in online market research and provides on-demand consumer insights through a qualitative platform. The company facilitates one-on-one online interviews, enabling businesses and organizations to connect with their target audiences effectively. GutCheck aims to innovate the market research process by offering real-time, affordable solutions tailored to meet the needs of its clients.

PerfectServe

Series D in 2015
PerfectServe, Inc. is a healthcare technology company based in Knoxville, Tennessee, that specializes in secure communication and collaboration solutions for healthcare providers across the United States. Founded in 1999, the company has developed a platform that includes various services such as clinical communication, provider scheduling, nurse communication, and medical answering services. PerfectServe's offerings, including PerfectServe Synchrony, enable seamless interaction among physicians, nurses, and other care team members, facilitating efficient patient care. The company has experienced significant growth, serving over 130 markets and facilitating tens of thousands of daily interactions between healthcare clients and approximately 12 million patients. Its solutions are designed to improve the accuracy, reliability, and control that medical professionals have over their communication processes.

River Branch Holdings

Acquisition in 2015
River Branch Holdings LLC, an international merchant bank, was founded to provide differentiated solutions in Investment Banking and Investment Management. Our business revolves around partnerships — partnering with our clients, our investors and our stakeholders. With well over 100 years of combined expertise, River Branch offers its partners insightful knowledge, hands-on experience and long-term relationships.

Lattice Engines

Series D in 2015
Lattice Engines, Inc. is a software company that develops SaaS-based predictive applications tailored for marketing and sales organizations. Founded in 2006 and headquartered in San Mateo, California, Lattice provides a suite of solutions designed to enhance sales and marketing effectiveness. Key offerings include Lattice Atlas, which integrates multiple data sources to build targeted audiences using artificial intelligence, and Lattice for Salesforce, which delivers sales analytics. The company also offers predictive insights for marketing programs through Lattice for Marketo, as well as tools for lead scoring, customer retention, and targeted selling strategies. These applications leverage advanced machine learning to analyze buying signals and improve marketing performance. Lattice has established a strategic partnership with Engagio Inc. and operates additional offices in Austin, Boston, and New York. As of July 2019, it functions as a subsidiary of The Dun & Bradstreet Corporation.

SportsEngine

Series D in 2014
SportsEngine, Inc. is a prominent provider of web and mobile application software designed for sports relationship management. Established in 2004 and based in Minneapolis, Minnesota, the company offers a comprehensive suite of tools for managing teams, leagues, and tournaments. Its products include SportsEngine for team management, TeamUnify for swim team administration, GoMotion for class-based sports, Trackwrestling for wrestling event management, Tourney Machine for tournament organization, and RallyMe for fundraising initiatives. Serving over 500,000 sports teams, leagues, clubs, and associations, SportsEngine facilitates communication and connections among a wide range of stakeholders, including athletes, parents, coaches, and fans.

Edgeview Partners

Acquisition in 2013
Edgeview Partners is a specialized investment bank serving the unique merger and acquisition (M&A) advisory needs of middle-market clients. Founded in 2001, our firm advises clients across the United States and Canada in virtually all industries, typically working with companies ranging in enterprise value from $25 million to $500 million. Our main focus is on the sale of privately held companies backed by entrepreneurs, families or private equity groups, as well as divisions of larger corporations. We also have extensive experience advising on growth capital raises, recapitalization transactions and buy-side acquisitions. Our qualified team of professionals has diverse expertise advising on middle-market mergers and acquisitions, having completed over 350 successful transactions throughout their careers. We combine senior-level commitment and significant resources to deliver unmatched client service. Our creativity and superior results for a broad spectrum of clients have been recognized with numerous industry awards, including recognition by The M&A Advisor as Boutique Investment Bank of the Year and multiple Deal of the Year awards.

Vitals

Series C in 2013
Vitals Consumer Services, LLC specializes in healthcare transparency and engagement solutions for consumers, employers, and health plans. Established in 2006 and headquartered in Lyndhurst, New Jersey, the company offers various tools to assist individuals in navigating their healthcare options. Among its key offerings are an online search tool for finding doctors, a healthcare transparency platform that clarifies health benefits and care choices, and an incentive program that rewards patients for selecting cost-effective care. Vitals serves over 280 million people annually, helping them make informed decisions about their healthcare. As of August 2018, Vitals operates as a subsidiary of WebMD Health Corp, with additional locations in New York, Tulsa, Westborough, and Bedford.

Torax Medical

Series D in 2012
Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.

Athersys

Post in 2012
Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life. The product development portfolio of the Company includes MultiStem, a stem cell product, which is being developed as a treatment for multiple disease indications, and is being evaluated in two ongoing clinical trials, and has been authorized for use in a third clinical trial. In addition, the Company is developing pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, and narcolepsy or other forms of excessive daytime sleepiness.

PerfectServe

Series C in 2012
PerfectServe, Inc. is a healthcare technology company based in Knoxville, Tennessee, that specializes in secure communication and collaboration solutions for healthcare providers across the United States. Founded in 1999, the company has developed a platform that includes various services such as clinical communication, provider scheduling, nurse communication, and medical answering services. PerfectServe's offerings, including PerfectServe Synchrony, enable seamless interaction among physicians, nurses, and other care team members, facilitating efficient patient care. The company has experienced significant growth, serving over 130 markets and facilitating tens of thousands of daily interactions between healthcare clients and approximately 12 million patients. Its solutions are designed to improve the accuracy, reliability, and control that medical professionals have over their communication processes.

Biohorizons.com

Private Equity Round in 2011
BioHorizons is committed to developing evidence-based and scientifically-proven products. This commitment started with the launch of the Maestro implant system in 1997 and remains in full force today with our most recent launches, the Tapered Plus and Tapered 3.0 implant systems. The focus of BioHorizons on science, innovation and service enables our customers to confidently use our comprehensive portfolio of dental implants and biologics products making BioHorizons one of the fastest growing companies in the dental industry.

Living Proof

Series B in 2011
Living Proof, Inc. is a hair care product manufacturer based in Cambridge, Massachusetts. Founded in 2005, the company focuses on using advanced technology and scientific research to address common beauty challenges. Its extensive product line includes shampoos, conditioners, styling treatments, and various creams and sprays designed to improve the health and appearance of hair. Living Proof's offerings cater to all hair types, including color-treated hair, ensuring that consumers can achieve their desired hair goals. The company distributes its products through its online store as well as through salons, retailers, and specialty beauty outlets in several countries, including the United States, Canada, the United Kingdom, Australia, Singapore, and Thailand. Living Proof operates as a subsidiary of Unilever PLC and has garnered a reputation for developing innovative formulas based on new molecules and breakthrough technologies.

IDEV Technologies

Series D in 2010
IDEV Technologies is an emerging growth medical device company focused on the development of products for endovascular and interventional applications. Currently, IDEV markets SUPERA, a novel self-expanding nitinol stent. Using a patented interwoven design, SUPERA offers improved flexibility, radial strength, and kink and crush resistance compared to other marketed stents. SUPERA is currently approved for use in the treatment of biliary strictures in the US. IDEV is currently enrolling patients in the SUPERB IDE trial to study SUPERA's safety and efficacy when used in the superficial femoral artery (SFA).

Advisory Research

Acquisition in 2009
Advisory Research, Inc. is a privately owned investment manager. The firm primarily provides its services to high-net-worth individuals, banking or thrift institutions, investment companies, pension and profit-sharing plans, university endowments, private and public foundations, corporations, state or municipal government entities, limited partnerships, and WRAP programs. It manages separate client-focused equity portfolios. The firm launches and manages equity mutual funds and hedge funds for its clients. It invests in the public equity and fixed income markets across the globe. The firm primarily invests in value stocks of micro-cap, small-cap, mid-cap, and large-cap companies. It makes investments in micro-cap companies with market capitalizations below $300 million and its international investments in companies with market capitalizations below $4 billion. The firm employs a fundamental analysis with a bottom-up stock picking approach to make its investments. It conducts in-house research to make its investments. The firm was founded in 1974 and is based in Chicago, Illinois. Advisory Research, Inc. operates as a subsidiary of Ostara Inc.

Vidacare

Venture Round in 2009
Vidacare Corporation, a medical device company, engages in the development, manufacture, and marketing of intraosseous access devices for diagnostic, monitoring, and therapeutic applications. The company provides EZ-IO Product System, which is designed to provide controlled vascular access through the intraosseous route to patients in emergent situations when vascular access is challenging and impossible. It also offers EZ-IO power driver, which is designed to penetrate the intraosseous space by drilling through the bone with a hollow needle and integrated stylet that doubles as the forward cutting bit to secure its correct placement; and EZ-IO Vascular Access Pack, a kit developed for emergency medical specialists to provide access to IV and IO devices to gain vascular access. In addition, the company provides a suite of hematology/oncology products, including a power driver and needle sets for bone marrow aspiration and biopsy; and OnControl, a bone marrow system for clinicians to perform bone marrow aspiration and biopsy procedures. Its products are used in pre-hospital, emergency, crash cart, and rapid response applications, as well as in military and homeland security industries. Vidacare Corporation was founded in 2001 and is headquartered in San Antonio, Texas.

eFashion Solutions

Venture Round in 2006
eFashionSolutions is the leading provider of online flagship stores to the branded fashion apparel/accessories, entertainment, and specialty retail industries. The eFashionSolutions e-commerce services are supported by a comprehensive technology platform. Services include buying and merchandising, design, photography, e-marketing, business intelligence, customer service, order management, and fulfillment functions. The Company is led by apparel and retail executives with extensive experience in merchandising, branding, customer service, and the technology solutions required to effectively manage and grow an online retail business. In 2006, eFashionSolutions was named to the Inc. 500 and NJ Finest 50. In 2007, the company received the USPS Strategic Business Development Award for their global shipping program, was named a finalist by the Extended Retail Institute in the Multi-Channel category, and received a Webby Award Nomination for DKNY.com. eFashionSolutions ships to over 120 countries internationally.

RewardsPlus

Venture Round in 2005
RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.

Suros Surgical Systems

Venture Round in 2004
Suros Surgical Systems, Inc. is an award winning Indiana-based medical device manufacturer setting new industry standards for minimally invasive methods of tissue excision and biopsy within multiple surgical specialties. Their patented surgical platform technology allows us to remove tissue or biopsy samples in the most compassionate, effective and efficient manner possible. Their initial product launch – the patented ATEC™ (Automated Tissue Excision and Collection) breast biopsy and excision system – has made exciting new clinical advancements in the areas of vacuum assisted diagnostic breast biopsy. Suros is proud to be the only company in the world with a commercially available MRI-guided vacuum assisted breast biopsy system that allows women in a high-risk population the opportunity for early diagnosis without going to surgery. For the more than 1.2 million women who undergo breast biopsy every year, this is good news. Suros also offers the first and only 9 gauge petite needle for women with small breasts and a true 12 gauge needle – giving physicians the world’s smallest needle to perform the world’s fastest breast biopsy. At Suros, they believe patients are better served with a minimally invasive approach to biopsy or surgery. The ATEC™ system offers measurable improvements in speed, reliability, clinical capabilities, safety, economic return, and ease of use. Simply stated, the ATEC™ is the choice both physicians and women have been waiting for – a breast biopsy system compatible under any imaging modality and first-ever technology that allows women a chance at outpatient breast biopsy methods with reduced pain and trauma, and with no scarring or post-op recovery time. Suros never stops improving its technology and is always looking for new, innovative ways of providing the most compassionate patient care on many clinical levels. Stay tuned as Suros grows and continues to take the lead in developing new capabilities for minimally invasive tissue excision in even the most delicate surgical applications.

Axya Medical

Venture Round in 2004
Axya Medical is a U.S.-based company that offers knotless fixation systems for shoulder repair. The company provides knotless fixation systems, including control unit, handpiece, wielding sleeve, and sutures; and implants, including titanium implants, bioabsorbable implants, and super implants. Axya Medical also provides shoulder accessories such as removal tool, bone punch, bioabsorbable anchor tap, and drill guide with obturator; and general accessories, such as electrical cord, handpiece sterilization tray, protective horn sheath, suture separator, suture grasper, and arthroscopic suture cutter. It was founded in 1996 and is headquartered in Beverly, Massachusetts.

FieldCentrix

Series B in 2004
FieldCentrix provides mobile field service automation solutions for service lifecycle management. Its management solution, FieldCentrix Enterprise, automates and streamlines manual processes and centralizes disparate applications associated with field service. FieldCentrix delivers solutions for market sectors, including manufacturing, industrial equipment, automation controls, medical devices, high technology, communications, real estate services, and building trade services. The company was founded in 1994 and is headquartered in Irvine, California with offices in North America and Europe. As of September 21, 2005, FieldCentrix Inc. operates as a subsidiary of Astea International Inc.

InSound Medical

Series D in 2004
InSound Medical, Inc., a privately held, venture-backed company based in Newark, California, develops and manufactures next-generation hearing solutions. Major investors include Johnson & Johnson, DeNovo Ventures, CMEA Ventures, and Psilos Group Managers, LLC.

Insulet

Series D in 2004
Insulet Corporation is a medical device company that develops, manufactures, and sells insulin delivery systems for individuals with insulin-dependent diabetes. The company's primary product, the Omnipod System, consists of a disposable, tubeless insulin infusion device that adheres to the body for up to three days, along with a wireless personal diabetes manager for monitoring and control. Insulet markets its products through independent distributors and pharmacy channels, as well as directly to patients in the United States, Canada, Europe, and the Middle East. Founded in 2000, Insulet is headquartered in Acton, Massachusetts, and aims to enhance the quality of life for people managing diabetes through innovative technology.

PHT Corporation

Series E in 2003
PHT Corporation is a leading provider of electronic patient-reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers the LogPad and StudyPad Systems, which enhance data quality and facilitate efficient data collection. Additionally, PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to trial data, enabling informed decision-making. By leveraging these technologies, biopharmaceutical and medical device companies can obtain more comprehensive data and accelerate their trial processes, ultimately contributing to the success of clinical studies.

LipoScience

Series E in 2003
LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.

InSound Medical

Series D in 2003
InSound Medical, Inc., a privately held, venture-backed company based in Newark, California, develops and manufactures next-generation hearing solutions. Major investors include Johnson & Johnson, DeNovo Ventures, CMEA Ventures, and Psilos Group Managers, LLC.

ZettaCom

Series C in 2003
ZettaCom, Inc. manufactures and supplies chipset solutions to core multi-service switch and router original equipment manufacturers (OEMs).

Dynavax Technologies

Series D in 2002
Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company committed to discovering and developing novel products to prevent and treat infectious diseases.

BRONCUS

Series D in 2002
Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases. Broncus is investigating the Exhale emphysema product line to perform our patented treatment method called Airway Bypass. Airway Bypass could be the first minimally-invasive procedure for the treatment of homogeneous, or diffuse, emphysema, which constitutes the majority of the emphysema patient population. Broncus is currently enrolling patients worldwide in our pivotal EASE Trial investigating a treatment of severe homogeneous emphysema. Broncus is located in Mountain View, CA (San Francisco Bay area). Broncus International is located in Nyon, Switzerland.

Fluidigm

Series C in 2001
Fluidigm Corporation develops and markets innovative technologies and tools for life sciences research globally. The company specializes in integrated fluidic circuits that control fluids at the nanoscale, enabling a range of applications in biological research. Its product offerings include analytical systems such as the Helios CyTOF system, the Hyperion imaging system, and the Biomark HD system, along with various assays and reagents designed for immuno-oncology and genetic analysis. Fluidigm also provides preparatory instruments and single-cell microfluidics, such as the C1 and Polaris systems. The company serves a diverse clientele, including academic institutions, clinical research laboratories, biopharmaceutical, biotechnology, and agricultural biotechnology companies, focusing on non-diagnostic and non-clinical applications. Established in 1999 as Mycometrix Corporation, it adopted the name Fluidigm Corporation in 2001 and is headquartered in South San Francisco, California.

PHT Corporation

Series D in 2001
PHT Corporation is a leading provider of electronic patient-reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers the LogPad and StudyPad Systems, which enhance data quality and facilitate efficient data collection. Additionally, PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to trial data, enabling informed decision-making. By leveraging these technologies, biopharmaceutical and medical device companies can obtain more comprehensive data and accelerate their trial processes, ultimately contributing to the success of clinical studies.

Oresis Communications

Venture Round in 2001
Oresis Communications designs and develops switching systems for carrying voice and data signals on the same telecommunications network. It offers ISIS-700 OmniService Switch, which enables carriers and service providers to migrate circuit and packet switched networks to a single backbone; and ISIS-700 Integrated OmniService Switch, which is a multiservice switch equipment that switches multiple voice, data, Internet, and video services in a single system. The company is based in Beaverton, Oregon.

Chameleon Systems

Series C in 2001
Chameleon Systems is a privately held fabless semiconductor company that designs, markets and sells programmable system-on-a-chip solutions for the communications electronics markets. Headquartered in San Jose, California, the company has developed the industry´s first reconfigurable communications processor (RCP)--an ideal solution for data-intensive Internet, DSP, wireless basestations, voice compression, software-defined radio, and other high-performance embedded telecom and datacom applications. The Chameleon RCP solution allows data and telecom equipment vendors to create customized communications signal processors to increase performance and channel count, more quickly adapt to new requirements and standards, reduce time-to-market, lower development costs and reduce risk.

Lara Networks

Series B in 2000
Lara Technology is a fabless semiconductor manufacturer that designs, develops and markets memory-intensive ASICs for the networking and communications industries.

PHT Corporation

Series C in 2000
PHT Corporation is a leading provider of electronic patient-reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers the LogPad and StudyPad Systems, which enhance data quality and facilitate efficient data collection. Additionally, PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to trial data, enabling informed decision-making. By leveraging these technologies, biopharmaceutical and medical device companies can obtain more comprehensive data and accelerate their trial processes, ultimately contributing to the success of clinical studies.

RewardsPlus

Venture Round in 2000
RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.

DynamicSoft

Series B in 2000
DynamicSoft provides carrier-class infrastructure software for packet-based wireline and wireless communications networks. The company's infrastructure solutions enable carriers and communications application service providers to deploy telephony applications and converged services over Internet protocol-based networks. Its dynamicsoft Service Engine allows mobile carriers to deliver voice and data services over packet network, as well as provides a migration path to various IP 3G network environments; supports various services, such as voice, multimedia messaging, instant messaging, and presence; and consolidates common functions, which include customer data storage, authentication, authorization, provisioning, and service interaction. The company was founded in 1998 and is based in East Hanover, New Jersey.

Instill

Venture Round in 2000
As per the transaction announced on April 21, 2008, Instill Corporation was acquired by iTradeNetwork, Inc. Instill Corporation provides spend intelligence solutions for the foodservice industry. It offers supply chain information services, which automates the collection of transactional and process-oriented data from its customers trading partners. The company also provides a suite of hosted applications that helps its customers in managing various business processes, including trade spend management, food spend management, quality and regulatory compliance, promotion management, procurement, food safety, and vendor and product management. It offers its solutions to foodservice manufacturers, operators, and distributors. Instill Corporation was founded in 1993 and is headquartered in San Mateo, California.

Lifespire

Venture Round in 2000
Lifespire was created in late 1999 through the merging of 2 companies: Vida Healthcare and inspiria.com. Vida Healthcare, formed in 1996, has worked with hundreds of oncology doctors, nurses and allied health professionals to improve cancer care. Lifespire Their vision is to improve care through shared knowledge. But what does that mean to you, the patient, and your circle of family and friends They serve? It means that They are giving you and the ones closest to you -- your circle of care -- a resource for gathering credible knowledge, support and understanding of your experience with cancer. Some of you may have known us when They were Vida Healthcare. In Their four years as Vida, They delivered clinical support and education services to over 4,000 people experiencing cancer. Now They're bringing that experience and understanding to you. They're doing this in partnership with companies committed to improving the treatment of cancer. And They're using Lifespire.com as Their forum for delivery.

RewardsPlus

Series D in 2000
RewardsPlus is a provider of benefits management technology. RewardsPlus' Benfinity system is a suite of Web-based applications and professional services designed to simplify and automate employee benefits communication, self-service enrollment and ongoing post-enrollment administration. Serving many nationally recognized corporations such as Unilever, AT&T, and National City Corporation.

Applicast

Venture Round in 1999
Applicast™, Inc. is the premier, total-solution application service provider (ASP) for aggressive-growth companies. The Applicast Business Applications Network™ offers full-service application outsourcing for mission-critical applications, such as SAP and Siebel, over secure private or Internet connections. Applicast’s unique combination of a world-class application portfolio, targeted FastFit™ Solutions and full-lifecycle services enables its clients to slash the time, costs and risks of deploying top-tier systems. Applicast, which was formerly called Plenan Systems, is a privately held, venture-backed organization.

Centromine

Venture Round in 1999
Centromine offers a browser-based, internet-accessed, enterprise-wide software applications and services for the health care market. Its applications allow behavioral health care programs and providers to manage the delivery and associated quality and cost of services completely over the internet.

PHT Corporation

Series B in 1999
PHT Corporation is a leading provider of electronic patient-reported outcome (ePRO) solutions utilized in clinical trials globally. The company offers the LogPad and StudyPad Systems, which enhance data quality and facilitate efficient data collection. Additionally, PHT's StudyWorks online portal grants study sponsors, monitors, and sites real-time access to trial data, enabling informed decision-making. By leveraging these technologies, biopharmaceutical and medical device companies can obtain more comprehensive data and accelerate their trial processes, ultimately contributing to the success of clinical studies.

HeartStent

Venture Round in 1999
HeartStent is a cardiovascular device firm. It is a direct revascularization device intended for coronary artery disease patients currently treated with coronary artery bypass grafts.

Chameleon Systems

Series B in 1999
Chameleon Systems is a privately held fabless semiconductor company that designs, markets and sells programmable system-on-a-chip solutions for the communications electronics markets. Headquartered in San Jose, California, the company has developed the industry´s first reconfigurable communications processor (RCP)--an ideal solution for data-intensive Internet, DSP, wireless basestations, voice compression, software-defined radio, and other high-performance embedded telecom and datacom applications. The Chameleon RCP solution allows data and telecom equipment vendors to create customized communications signal processors to increase performance and channel count, more quickly adapt to new requirements and standards, reduce time-to-market, lower development costs and reduce risk.